Post My Press Release

Free Press Release Distribution

Author: Sumaiya234 (Page 1 of 32)

Empty Capsule Market – The Biggest Trends to watch out for 2019-2023

Global Empty Capsule Market Report Split Into Several Key Regions, With Sales, Revenue, And Market Share And Growth Rate. Covering North America, Europe, Asia Pacific, Middle East and Africa.

Market Analysis:

The Global Empty Capsule Market is predicted to have a promising growth at a striking 8.8% CAGR over the forecast period (2018-2023). Capsules provide a viable substitute to tablets especially for its wide availability and easy administration. A capsule is a stable shell which is utilized to encapsulate active ingredients that are formulations possessing therapeutic activity. It is widely used in pharmaceutical industries especially when it is difficult to compress a drug in a solid tablet.

An empty capsule is an oral dosage which resting on the manufacturing material type is available in assorted colors and sizes such as flavored capsules and pearl capsules. Capsules are available in different types such as rectal capsules, enteric coated capsules, sustained release capsules, hard gelatin capsules and soft gelatin capsules. Hard and soft capsules are the commonly used empty capsules. An empty capsule comes in assorted sizes that helps in customization and dose calibration as per the needs of the individual.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7153

Capsules are highly favored as it is easy to swallow, have an odorless and tasteless gelatin coating that makes it palatable, causes decreased gastrointestinal irritation and have quicker dissolution times compared to other forms of oral dosage.

There are many factors that is driving the growth of the empty capsule market. Some of these factors as per the Market Research Future (MRFR) report include increasing use of capsule formulations amid the geriatric population, rising research and development activities and clinical trials, advancements in the capsule delivery technology, growth of pharmaceutical market, easy digestibility, easy to consume, ease of availability, rising consumer preference for capsules over tablets and surge for nutraceutical products. On the contrary, factors such as constricted regulatory guidelines laid down by the international and national regulatory authorities, lack of advanced medicinal facilities especially in under-developed nations, high initial investment, scarcity of skilled healthcare experts, prerequisite R&D, increasing raw material prices, religious and cultural issues associated to capsule consumption having animal-derived ingredients such as bovine and porcine gelatin capsule shells may hinder the growth of the empty capsule market.

Key Players:

Leading players profiled in the empty capsule market include Arab Caps, Sunil Healthcare Limited, NecLife, ACDIMA, Capsugel, Medi-Caps Ltd, ACG-Associated Capsules, QUALICAPS, Roxlor, Julphar, Tabuk Pharmaceuticals, Neopharma and others.

Segmentation:

Market Research Future report offers an all-inclusive segmental analysis of the empty capsule market on the basis of raw materials, physical characteristics, certification and end user.

Based on raw materials, it is segmented into non-gelatin, porcine and bovine.

Based on physical characteristics, the empty capsule market is segmented into soft and hard capsules. Of these, soft capsules will have the largest market share over the forecast period.

Based on certification, it is segmented into non-halal certification, halal certification and others. Of these, halal certification will lead the empty capsule market.

Based on end-user, the empty capsule market is segmented into academic and research organizations, pharmaceutical industries and others. Of these, the pharmaceutical industries are anticipated to have the largest share in the market.

Regional Analysis:

Based on region, the empty capsule market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and the Middle East and Africa. Of these, North America is anticipated to grab the largest share in the market due to high healthcare expenditure, well-developed technology and huge patient population. The empty capsule market in Asia Pacific will have the second biggest share followed by Europe. The market in the APAC region is the fastest growing due to the quickly changing healthcare sector. On the other hand, the empty capsule market in the Middle East and Africa will have minimum share due to the existence of slow and poor developing countries particularly in the African region. The market in the Middle East will have a major share owing to high spending and well-developed infrastructure.

Browse Complete 90 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/empty-capsule-market-7153

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Cochlear Implants Market Rapidly Growing in Healthcare, Competitor Analysis, and Complete Study lo of Current Trends and Forecast 2019-2023

MRFR Provides Appropriate Analysis of Global Cochlear Implants Market by Geographical Analysis, Scope, Applications, Products, Prominent Audience, End Users, and Market Players for Global, and Country Level Market Segments, etc

Cochlear Implants Market – Overview

Global Cochlear Implants Market will surpass a valuation of USD 3,200 Mn by the year 2023, reflecting an above-average CAGR of 9.89%. Cochlear implants can improve hearing capabilities. Such implants are high advanced as compared to traditional hearing aid devices.

At the same time, efforts are being made to improve the quality and effectiveness of cochlear implants. Over the past couple of years, demand for cochlear implants has increase significantly. DeafandHoH.com, LLC. revealed that close 360 Mn people were suffering from moderate to severe hearing loss globally in 2014.

The number of people accepting such treatment for their hearing issues have increased considerably in recent years. The National Institute on Deafness and Other Communication Disorders stated that in the year 2013, nearly 324,200 registered devices were implanted across the globe.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5256

The Centers of Disease Control and Prevention projected that by 2025, approximately 900 Mn people worldwide are expected to suffer from hearing loss. These is a substantial market opportunity for cochlear implants market. Factors such as rising incidence of hearing loss, increased geriatric population, increased awareness, favorable reimbursement policies and innovation in hearing implants are expected to support the market’s growth during the forecast period. Furthermore, increased government support and rising healthcare expenditure are other important factor influencing the market. Nonetheless, the high cost of implant and treatment procedures continues to hamper the market proliferation in developing countries.

Key Players:

MRFR in its report has profiled some of the top-notch companies functioning in the global cochlear implants market, which include MED-El (Austria), GAES MÉDICA (Spain), Widex (Denmark), Microson S.A. (Spain), Advanced Bionics AG (Switzerland), William Demant Holding Group (Denmark), and Cochlear Ltd (Australia).

Segments:

The MRFR’s report also includes detailed segmental analysis of the market based on type, product, end user and region. By type, the market has been segmented into bilateral implant and unilateral implant. Based on products, the market has been segmented into accessories & upgrades and cochlear implants system. The cochlear implant system type segment currently accounts for the lion’s share of the market and expected to remain high profitable during the assessment period. By end user, the market has been segmented into ambulatory surgical centers, hospitals & clinics research & academic institutes and others.

Region Analysis:

Regions that are cover in the report include Americas, Europe, the Middle East & Africa (MEA) and Asia Pacific (APAC). The Americas currently account for the largest market share in term of value. This is primarily due to factors such as existence of a massive patient pool, advanced healthcare infrastructure, high-healthcare spending, rampant R&D efforts and strong government support. Moreover, presence of various prominent market players in the countries such as the U.S and Canada aids in placing the region at a favorable position in the global cochlear implants market. Meanwhile, Europe is likely to hold its second position in the global cochlear implants market throughout the review period. Presence of several advanced economies in Europe, especially in West Europe is a major supporting factor for the region’s market. Europe is followed by Asia Pacific, which is the third largest market for cochlear implants. Rising healthcare expenditure along with the improving caregiving services is creating opportunities for market players. The market in APAC is anticipated to exhibit a comparatively faster growth over the next couple of years. In the MEA, the market is projected to grow at a moderate pace however, increased focus on improving healthcare system is creating attractive prospects for the market in the region. The GCC countries are likely to play an important role in driving the market in MEA.

Europe is the second largest market for Cochlear Implants which is expected to exhibit healthy growth over the forecast period. High investment in R&D activities and new product approvals are initiating growth in the region. Well spread awareness, and key players are focusing on market expansion in the region acts as a plus for the growth of the market.

APAC is expected to showcase impressive growth over the forecast period. The region has large unmet needs among the massively populated countries in the region which provide ample opportunities for market expansion. To capitalize on the available growth opportunities and the availability of a cheap skilled workforce, lower operating cost and abundance of raw materials, key players are shifting their production base in the region. This has resulted in the availability of cost-competitive varieties of Cochlear Implants which has further intensified the growth of the APAC Cochlear Implants market.

Browse Complete 83 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at

https://www.marketresearchfuture.com/reports/cochlear-implants-market-5256

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

New Study: 2019-2023 Global Medication Management Industry Trend and Forecast Report

MRFR Provides Appropriate Analysis of Global Medication Management Market by Geographical Analysis, Scope, Applications, Products, Prominent Audience, End Users, and Market Players for Global, and Country Level Market Segments, etc

Medication Management Market – Overview

Global Medication Management Market is expected to grow at an approximate CAGR of 13.4% during forecast period, 2018–2023. Improvement in medication management workflow of hospitals is the key factor driving the medication management market. For instance, in 2015, Hospital Israelita Albert Einstein (HIAE) enterede an agreement with Swisslog Healthcare Solutions for material transport and medication management to re-engineer its pharmacy processes.

Various other factors such as increasing number of healthcare organizations across the globe, advancement in medical technology, and global adoption of IT in the healthcare sector are also boosting the market growth. However, high software implementation and service maintenance costs restraints the market growth during the forecast period.

Request Sample Copy at https://www.marketresearchfuture.com/sample_request/7187

Prominent Players:

Some of the key players in the global medication management market are Allscripts Healthcare Solutions, Inc., Carefusion Corporation (BD), Cerner Corporation, Epic Systems Corporation, General Electric Company, Mckesson Corporation, Medical Information Technology, Inc., Omnicell, Inc., Optum Inc., QuadraMed Affinity Corporation, Siemens Ltd and others.

On the other hand, the high cost of gel documentation systems with advanced technologies and the increasing adoption of quantitative polymerase chain reaction (QPCR) may hamper the market growth during the assessment period.

Segmentation:

The Global medication management market is segmented based on systems, services, mode of delivery, end user and region.

The global market for medication management, by systems is segmented into computerized physician order entry systems, clinical decision support systems, administration software, inventory management systems, automated dispensing systems and assurance systems. The administration software is further classified as electronic medication administration records (eMAR) software and bar code medication administration (BCMA) software. The automated dispensing systems segment is further classified as centralized automated dispensing systems and decentralized automated dispensing systems (ADS). The centralized automated dispensing system includes robots/robotic automated dispensing systems and carousels. The decentralized automated dispensing system (ADS) includes pharmacy-based decentralized automated dispensing systems, ward-based decentralized automated dispensing systems and automated unit-dose decentralized automated dispensing systems.

The market by services segment is divided into point-of-care verification services and adverse drug effects (ADE) surveillance services.

The market by mode of delivery segment is divided into web-based solutions, on-premise solutions and cloud-based solutions.

Based on end-user, the market is segmented into hospitals, pharmacies and others.

Regional Analysis:

The Americas dominated the global market for medication management. This can be attributed to the increasing geriatric population and presence of major market players within the region.

Europe stood second in 2017 owing to the presence of developed economies like UK, Germany, France, and others within the region provides a driving force for the market to grow.

Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing healthcare IT sector, increasing penetration of the market players within the region, and increasing government’s support for foreign investments drives the regional markets of the Asia Pacific region.

On the other hand, the Middle East and Africa held least share in the global medication management market due to the presence of poor economies and low per capita income, especially within the African region. The Middle Eastern region is estimated to be a major market for the Middle East and African region.

Browse Complete 90 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/medication-management-market-7187

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Intraocular lens Market Production, Share, Demand, Applications and Opportunities Market Research Report 2023

MRFR Provides Appropriate Analysis of Global Intraocular Lens Market by Geographical Analysis, Scope, Applications, Products, Prominent Audience, End Users, and Market Players for Global, and Country Level Market Segments, etc

Intraocular Lens Market – Overview

Global Intraocular Lens Market is expected to register a CAGR of ~ 5.43% during the forecast period of 2018–2023 with an estimated market value of USD 3.54 billion in 2017. Intraocular lens is implanted inside the eye substituting the eye’s natural lens. These lenses are very effective in nature and are used for the correction of numerous eye defects such as astigmatism, presbyopia, near-sightedness (myopia), and among others.

The rising prevalence of eye diseases, and high rate of adoption of premium intraocular lens technology is expected to drive the growth of the market extensively. Also, increase in the geriatric population and the rise in diabetic population is estimated to drive the growth of the intraocular lens market. According to the data published in 2015 by the Centers for Disease Control and Prevention (CDC), Refractive errors are the most frequent eye problems in the US. Also, according to the report published in 2016 by National Eye Institute, proper refractive eye correction could improve vision among 11 million Americans aged 12 years and older.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7264

Factors such as post-operative complications, high cost of intraocular lens, and lack of skilled medical professionals are restraining the growth of market. Also, lack of reimbursement policies for premium lens in many developing and underdeveloped regions is anticipated to hinder the growth of the intraocular market.

The global intraocular lens market is currently dominated by many market players. The key players in the market are involved in strategic collaborations and new product launches to brace its market position. For instance, in December 2018, Bausch + Lomb, a wholly owned subsidiary of Bausch Health Companies Inc., received 510(k) clearance from the US Food and Drug Administration (FDA) for Bausch + Lomb ULTRA Multifocal for Astigmatic correction. Thus, the company broadened its product portfolio to hold its position in the market.

Competitive Analysis:

Some of the key players in the global intraocular lens market are Alcon, Inc., Bausch + Lomb, Eyekon Medical, Inc., Carl Zeiss Meditec, Johnson & Johnson Vision Care, Inc., HOYA Corporation, STAAR Surgical Company, Rayner Intraocular Lenses Limited, PhysIOL, Ophtec BV, Humanoptics AG, Lenstec, Inc., Oculentis GmbH, Aurolab, and Nidek Co., Ltd.

Segmental Analysis:

The global intraocular lens market has been segmented into type, material and end user. The market, based on type, has been segmented into monofocal intraocular lens, multifocal intraocular lens, accommodating intraocular lens, phakic intraocular lens, and others.

The market, by material, has been segmented into hydrophobic acrylic, hydrophilic acrylic, polymethylmeth-acrylate (PMMA), and others.

The market, by end user has been segmented into hospitals, ophthalmic clinics, ambulatory surgical centers, and others.

Regional Analysis:

The market in the Americas is expected to dominate the global intraocular lens market during the forecast period owing to the rising healthcare expenditure. In addition, proactive government initiatives to spread awareness about the benefits of intraocular lens among the masses have supplemented the market growth. Europe is expected to hold the second largest position in the global intraocular lens market. The market growth in this region is attributed to the existence of a well-established healthcare system and increase in insurance coverage. Asia-Pacific is estimated to be the fastest growing region in the market due to the improving healthcare infrastructure. The market in the Middle East & Africa is likely to account for the smallest share of the global intraocular lens market.

Browse Complete 160 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/intraocular-lens-market-7264

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Global Healthcare Information Systems Market 2019 Trends and Competitive Landscape Outlook -2023

MRFR Provides Appropriate Analysis of Global Healthcare Information Systems Market by Geographical Analysis, Scope, Applications, Products, Prominent Audience, End Users, and Market Players for Global, and Country Level Market Segments, etc

Healthcare Information Systems Market – Scenario

Global Healthcare Information Systems Market is expected to grow at an approximate CAGR of 10.0% during forecast period, 2018–2023.

Health care information technology has shown to improve the quality of healthcare sector by enhancing disease surveillance, increased adherence to guidelines, and decreasing medication errors. The global health care information systems market has expanded rapidly over the years, and there has been a noticeable rise in adoption of health care information systems in recent times. Use of health care information systems in electronic prescriptions, medication management and intelligent wearable technologies to limit lifestyle diseases, and smart robots to systemize repetitive tasks is expected to significantly reduce health care costs and boost the market.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7325

Top Players:

Some of the key players in the global healthcare information systems market are Agfa-Gevaert N.V.

Allscripts Healthcare Solutions Inc., Athenahealth Inc., Carestream Health, Cerner Corporation

GE Healthcare, McKesson Corporation, Medidata Solutions Inc., NextGen Healthcare, Philips Healthcare, Siemens Healthineers.

Segmentation:

The global healthcare information systems market is segmented based on type, components, deployment, end user, and region.

On the basis of type, the market is segmented into hospital information systems, pharmacy information systems, laboratory information systems, medical imaging information system, revenue cycle management. The hospital information systems segment is sub-segmented into electronic health record, electronic medical record, real-time healthcare, patient engagement solutions, population health management and others. The pharmacy information systems segment is sub-segmented into prescription management, automated dispensing systems, inventory management and others. The medical imaging information System is sub-segmented into radiology information systems, monitoring analysis software, picture archiving & communication systems and others. Based on components, the market is divided into two, i.e., Software and Hardware. Based on deployment, the market is divided into web-based, on premise and cloud-based. By end user, the market is divided into hospitals, diagnostics centre, academic and research institution, and others. On the basis of region, the market is segmented into the Americas, Europe, Asia Pacific and the Middle East & Africa.

Regional Analysis:

The Americas leads the global healthcare information systems market. This can be attributed due to growing elderly population and presence of major market players within the region. Moreover, the presence of developed economies like U.S. and Canada within the region boost the market growth.

 In 2017, followed by the Americas, Europe stood second in the global market owing to the presence of a well-developed healthcare infrastructure, increasing awareness and high healthcare expenditure. Asia Pacific was estimated to be the fastest growing region in 2017. This can be attributed due to the high contamination rate, increasing household income and growing penetration of the market players within the region. Moreover, rapidly growing pharmaceutical sector within the region boosts the market to grow. On the other hand, the Middle East and Africa held the least share in the global healthcare information systems market. This can be attributed due to the presence of poor economies, stringent government policies and low per capita income, especially within the African region. A majority of the of the market share within the Middle East & Africa is estimated to be held by the Middle East due to increasing government funding for healthcare, improving healthcare facilities and presence of developed economies like United Arab Emirates, Saudi Arabia, Kuwait, Dubai, and others.

Browse Complete 90 Pages Premium Research Report Enabled with Respective 30+ Tables and Figures at https://www.marketresearchfuture.com/reports/healthcare-information-systems-market-7325

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Global Nuclear Medicine Market 2019 Trends and Competitive Landscape Outlook -2023

Global Nuclear Medicine Market Report Split Into Several Key Regions, With Sales, Revenue, And Market Share And Growth Rate. 

Nuclear Medicine Market – Highlights

Global Nuclear Medicine Market divulges a number of vital figures and facts about the market. In 2017, the market was valued at USD 3.785 Bn in 2017 and is projected to grow at a CAGR of 6.2% over the review period. With the rapid expansion of advanced medical technologies, the market is expected to grow at a consistent upward trend to approximate market value of USD 5.430 Bn by the end of 2023.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6674

Nuclear Medicine is a branch of medicine which uses radioactive substances in small amounts for diagnosis and treatment of various diseases. Nuclear medicine can be used for the treatment of various conditions including blood disorder, and some cancers and use vastly different imaging technologies than those used in traditional imaging as they show physiological function of the particular system making it a more targeted method of imaging.

Nuclear medicine offers precise diagnostic abilities and is useful in the early detection of cancer as well as other diseases such as cardiovascular disorders. The increasing prevalence of cancer and other chronic diseases and a high demand for early diagnosis of such diseases for effective treatment is a significant driver of the global market.

Moreover, increasingly radiopharmaceuticals are being used for the diagnosis or treatment of chronic diseases in geriatric patients. The rapid expansion of this demographic is expected to encourage the growth of the market. The WHO has recorded astounding figures regarding the prevalence of cancer at nearly one out of every six deaths, making it one of the most significant causes for patient mortality, thus increasing the demand for nuclear medicine.

The promising future of the global nuclear medicine market is threatened by the high costs of radiopharmaceuticals which makes treatment unaffordable. Although it has not been proven to be distinctly harmful, erring on the side of safety has made patients wary of adopting nuclear medicine due to the side effects associated with exposure to radiation. However, market opportunities are expected to mitigate these threats to growth. Radioisotopes are witnessing increased usage for diagnostics and therapeutics as they offer the potential for learning medical information that is otherwise unobtainable. They have a wide range of applications in medical research which range from observing metabolic processes to tracing drug movement in biological systems.

Key Players:

Eminent market participants that have been included in MRFR’s report include Jubilant Lifesciences, Lantheus Medical Imaging, Mallinckrodt Pharmaceuticals, Medtronic plc, Bayer AG, Advanced Accelerators Applications, Nordion Inc., Cardinal Health, Bracco Imaging, Curium, and GE Healthcare.

Segmentation:

MRFR has conducted a detailed study of the various parts of the nuclear medicine market which has been segmented on the basis of product type, application, end-user, and region. By product types, the nuclear medicine market has been segmented into diagnostic nuclear medicine and therapeutic radiopharmaceuticals. At present, the diagnostic nuclear medicine segment has attained a leadership position. However, the therapeutic radiopharmaceuticals segment is the fastest growing segment during the forecast period. The diagnostic nuclear medicine segment is segmented further into SPECT radiopharmaceuticals, and PET radiopharmaceuticals. Meanwhile, the therapeutic radiopharmaceuticals segment is sub-segmented into alpha emitters, beta emitters, and brachytherapy isotopes.

Applications of nuclear medicine are segmented into diagnostic applications and therapeutic applications. Diagnostic applications is a major segment which is sub-segmented into SPECT applications and PET applications. Meanwhile, the therapeutic applications segment is growing at the fastest pace.

End-users have been segmented into hospitals & diagnostic centers, research institutes, and others. Research institutes display the highest potential for growth over the forecast period, while hospitals & diagnostics centers have been identified as the most significant segment in terms of market share.

All sub-segments have been segmented further and included in the report.

Regional Overview:

The Americas due to the presence of North America has established itself as a market leader. The presence of several important market players combined with the high prevalence of cancer and other chronic diseases has influenced the growth of the Americas nuclear market. The region, particularly countries such as U.S & Canada have well-developed healthcare sectors which receive high investments. Moreover, the region has a high geriatric patient population which is expanding rapidly and is growing increasingly aware regarding advanced therapies.

Browse Complete 125 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/nuclear-medicine-market-6674

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Patient Registry Software Market 2019: Market Share, Revenue and Cost Analysis with Key Company’s Profiles-Forecast to 2023

Global Patient Registry Software Market Report Split Into Several Key Regions, With Sales, Revenue, And Market Share And Growth Rate. Covering North America, Europe, Asia Pacific, Middle East and Africa. 

Patient Registry Software Market – Overview

Patient Registry Software Market is expected to have accounted for the market value of USD 930 million in 2017 and is projected to grow at a CAGR of 11.7% over the assessment period. The implementation of government initiatives to build patient registries, reduce healthcare costs and improve quality of care, increasing adoption of electronic health records, and increasing use of patient registry data for post-marketing surveillance boost the growth of the market during the forecast period.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6917

On the other hand, the data security-related concerns and lack of trained and skilled resources may hinder the market growth during the forecast period.

Key Players:

Some of the prominent players in the global patient registry software market are Dacima Software Inc. (US), Global Vision Technologies, Inc. (US), Phytel, Inc. (US), QUINTILES IMS HOLDINGS, INC. (US), Liaison Technologies (US), ImageTrend, Inc. (US), FIGmd, Inc. (US), McKesson Corporation (US), CECity.com Inc. (US), and ifa systems AG, (Germany).

Segments:

The global patient registry software market has been segmented into type of software, deployment model, type of registry, and end user.

On the regional basis, the global patient registry software market in the Americas is segmented into two major regions, i.e., North America and South America. The North American region is likely to hold the major share in the global patient registry software market owing to the presence of well-established palyers and increasing adoption of electronic health records systems. Additionally, the Asia-Pacific region is anticipated to be the fastest growing region for the patient registry software market.

Regional Analysis:

Geographically, the Americas is expected to dominate the global patient registry software market owing to the presence of well-established players, increasing use of patient registry data for post-marketing surveillance, and increasing adoption of electronic health records. Europe is expected to hold the second largest position in the global patient registry software market. Asia-Pacific is expected to be the fastest growing patient registry software market. Furthermore, the Middle East and Africa region is expected to account for the least market share in the global patient registry software market.

Browse Complete 100 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/patient-registry-software-market-6917

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Hemophilia Treatment Market Outlook and Forecast 2023: Growth Factors, Trends, and Top Companies Analysis for Business Development

Global Hemophilia Treatment Market Report Split Into Several Key Regions, With Sales, Revenue, And Market Share And Growth Rate. Covering North America, Europe, Asia Pacific, Middle East and Africa. 

Hemophilia Treatment Market – Overview

Hemophilia Treatment Market is expected to reach a valuation in excess of USD 16,000 Mn by the year 2023. MRFR projects that the market will exhibit an above-average CAGR of 6.10% during 2018 to 2023. Hemophilia is an inherited genetic blood disorder and holds a chronic status. People with hemophilia are likely to live with the condition throughout their life but the effects can be greatly reduced with the help of several hemophilia drug and therapeutics. The prevalence of hemophilia has increased across the globe in recent years. A higher level of awareness and high healthcare expenditure are two major factors that are driving the growth of haemophilia treatment market in the advanced countries in Americas and Europe.

Growing used of recombinant products is also reflecting favourably on the global market for hemophilia treatment. Recombinant products are an alternative to plasma derived products and considered relatively safer.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5688

Hemophilia drugs that are manufactured using recombinant products have proteins that are derived from genetically engineered cell lines and thereby have minimum or zero risk of contaminations. Demand for recombinant products is expected to remain high during the forecast period. Such factors are expected to support the growth of the market as well. In addition, regions such as the Middle East & Africa (MEA) and Asia Pacific (APAC) are also presenting lucrative growth opportunities to market players.

Hemophilia Treatment Market: Competitive Landscape

Bayer AG, Swedish Orphan Biovitrum AB, Pfizer Inc, Grifols International S.A, Octapharma, Baxter, F.Hoffmann-La Roche Ltd, CSL Behring, Novo Nordisk A/S, Kedrion, Sanofi and Shire are some of the key market participants mentioned in MRFR’s report.  

Hemophilia Treatment Market – Regional Analysis:

Based on regions, the hemophilia treatment market has been segmented into Europe, Americas, Asia Pacific (APAC), and the Middle East & Africa (MEA). Currently, the Americas region holds the largest share of the global haemophilia treatment market and is likely to retain its dominant position in 2018 and beyond.

North America in particular present significant growth opportunities to market owing to factors such as high healthcare expenditure and existence of an advanced healthcare system. Meanwhile, Europe has emerged as the second largest market for hemophilia treatment. Presence a large number prominent drug manufacture gives the Europe market an edge.

The market in APAC is also expected to witness a healthy growth during the forecast period. Rapid growth of the healthcare sector and introduction of favourable policies are attracting market players towards the region.

Hemophilia Treatment Market – Segmentation:

MRFR’s report also includes an in-depth segmental analysis of the global market for haemophilia treatment based on type, treatment type, end user and region. On the basis of type, the market has been segmented into hemophilia A, hemophilia B, and hemophilia C. Of these, the hemophilia A segment will continue to hold the largest share of the market over 2023. The segment is projected to reach a valuation of more than USD 12,600 Mn towards the end of review period, reflecting a healthy CAGR.

By treatment type, the market is segmented into plasma derived coagulation factor concentrate, recombinant coagulation factor concentrates, desmopressin, gene therapy and antifibrinolytic agents. The recombinant coagulation factor concentrates segment is expected to remain highly attractive during the assessment period. This is primarily owing to the high level of safety and efficacy offered by recombinant coagulation factor concentrates. In 2017, the segment stood at market valuation of USD 6,500 Mn.

By end user, the market is segmented into hospitals & clinics, research organization and others. By the year 2023, the hospitals & clinics segment is expected to surpass a market valuation of USD 11,000, exhibiting an impressive CAGR of 6.53%.

Browse Complete 158 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/hemophilia-treatment-market-5688

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Page 1 of 32

Powered by WordPress & Theme by Anders Norén